<![CDATA[Torqur AG 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=49161>Wed, 15 Apr 2026 06:38:26 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Bimiralisib, Topical PI3K/mTOR Inhibitor Shows Up To 92% Clearance Rate And Superior Tolerability In Proof-Of-Concept Actinic Keratosis Study]]>https://www.newswire.co.kr/newsRead.php?no=1020375Fri, 10 Oct 2025 17:20:00 +0900<![CDATA[국소 PI3K/mTOR 억제제인 비미랄리십, 광선각화증 개념증명 연구에서 최대 92%의 제거율과 우수한 내약성 달성]]>https://www.newswire.co.kr/newsRead.php?no=1020377Fri, 10 Oct 2025 17:20:00 +0900